Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C32H35N2O12S4.3H |
| Molecular Weight | 770.91 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 4 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H+].[H+].[H+].CC(\C=C\C=C1\N(CCS([O-])(=O)=O)C2=C(C=C(C=C2)S([O-])(=O)=O)C1(C)C)=C/C=C/C3=[N+](CCS([O-])(=O)=O)C4=CC=C(C=C4C3(C)C)S([O-])(=O)=O
InChI
InChIKey=WKWHOLCUESSZIQ-UHFFFAOYSA-N
InChI=1S/C32H38N2O12S4/c1-22(8-6-10-29-31(2,3)25-20-23(49(41,42)43)12-14-27(25)33(29)16-18-47(35,36)37)9-7-11-30-32(4,5)26-21-24(50(44,45)46)13-15-28(26)34(30)17-19-48(38,39)40/h6-15,20-21H,16-19H2,1-5H3,(H3-,35,36,37,38,39,40,41,42,43,44,45,46)
Omocianine was developed as an enhancer of fluorescence optical mammography allowed better detection of more superficially located lesions. It was shown that the lowest doses of omocianine performed best in lesion detection. Diffuse optical tomography using a low-dose fluorescent agent is feasible and safe for breast cancer visualization in patients. This compound participated in phase I clinical trials in Germany and in the Netherlands, however, these studies were discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Near-infrared imaging of breast cancer using optical contrast agents. | 2012-11 |
|
| Near-infrared imaging of the breast using omocianine as a fluorescent dye: results of a placebo-controlled, clinical, multicenter trial. | 2011-11 |
|
| A novel fluorescent imaging agent for diffuse optical tomography of the breast: first clinical experience in patients. | 2010-06 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19798535
Eleven women suspected of breast cancer were imaged with diffuse optical tomography at multiple time points (up to 24 h) after receiving an intravenous injection of Omocianine (doses 0.01 to 0.1 mg/kg bodyweight).
Route of Administration:
Intravenous
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C166847
Created by
admin on Mon Mar 31 18:30:36 GMT 2025 , Edited by admin on Mon Mar 31 18:30:36 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107764
Created by
admin on Mon Mar 31 18:30:36 GMT 2025 , Edited by admin on Mon Mar 31 18:30:36 GMT 2025
|
PRIMARY | |||
|
59529
Created by
admin on Mon Mar 31 18:30:36 GMT 2025 , Edited by admin on Mon Mar 31 18:30:36 GMT 2025
|
PRIMARY | |||
|
154082-13-0
Created by
admin on Mon Mar 31 18:30:36 GMT 2025 , Edited by admin on Mon Mar 31 18:30:36 GMT 2025
|
PRIMARY | |||
|
300000036994
Created by
admin on Mon Mar 31 18:30:36 GMT 2025 , Edited by admin on Mon Mar 31 18:30:36 GMT 2025
|
PRIMARY | |||
|
C570392
Created by
admin on Mon Mar 31 18:30:36 GMT 2025 , Edited by admin on Mon Mar 31 18:30:36 GMT 2025
|
PRIMARY | |||
|
8537
Created by
admin on Mon Mar 31 18:30:36 GMT 2025 , Edited by admin on Mon Mar 31 18:30:36 GMT 2025
|
PRIMARY | |||
|
DTXSID20165529
Created by
admin on Mon Mar 31 18:30:36 GMT 2025 , Edited by admin on Mon Mar 31 18:30:36 GMT 2025
|
PRIMARY | |||
|
5GD5D29K7I
Created by
admin on Mon Mar 31 18:30:36 GMT 2025 , Edited by admin on Mon Mar 31 18:30:36 GMT 2025
|
PRIMARY | |||
|
44147472
Created by
admin on Mon Mar 31 18:30:36 GMT 2025 , Edited by admin on Mon Mar 31 18:30:36 GMT 2025
|
PRIMARY |
ACTIVE MOIETY